Skip to main content
FinSpry Logo
FinSpry
VYGR logo
VYGR
(NASDAQ)
Voyager Therapeutics, Inc.
$3.40-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Voyager Therapeutics (VYGR) Stock Price & Financial Analysis

Voyager Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$3.38 - $3.50
52-Week High$5.55
52-Week Low$2.94
Open$3.48
Volume488.05K
Average Volume (3M)449.81K
Market Cap208.83M
Shares Outstanding59.50M
Price to Sales (P/S)5.72
Price to Book (P/B)1.20
EV/EBITDA-1.65
Revenue (TTM)36.49M
Net Income (TTM)-116.64M
Free Cash Flow (TTM)-129.94M
EPS (TTM)$-1.98
Profit Margin-319.61%
Operating Margin-349.16%
Return on Equity (ROE)-67.16%
Debt to Equity0.20
50-Day MA$3.31
200-Day MA$3.77
52-Week Change-20.19%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Voyager Therapeutics

What is the current stock price for VYGR?

As of the latest trading session, VYGR stock trades at $3.40. The 52-week range is $2.94–$5.55, with a day range of $3.38–$3.50.

What is the P/E ratio for VYGR?

The P/E ratio (Price-to-Earnings) for VYGR is shown in the Key Statistics section. This valuation metric helps compare Voyager Therapeutics, Inc. to industry peers.

Does VYGR pay dividends?

Voyager Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for VYGR?

Based on 3 analysts, the consensus for VYGR is Buy.

What is the market cap of VYGR?

Voyager Therapeutics's market capitalization is $202.3M, classifying it as a micro-cap company. Voyager Therapeutics operates in the Healthcare sector within the Biotechnology industry.